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Eating disorders may be viewed from a transdiagnostic perspective and there is evidence supporting a
transdiagnostic form of cognitive behaviour therapy (CBT-E). The aim of the present study was to
compare CBT-E with interpersonal psychotherapy (IPT), a leading alternative treatment for adults with
an eating disorder. One hundred and thirty patients with any form of eating disorder (body mass index
>17.5 to <40.0) were randomized to either CBT-E or IPT. Both treatments involved 20 sessions over 20
weeks followed by a 60-week closed follow-up period. Outcome was measured by independent blinded
assessors. Twenty-nine participants (22.3%) did not complete treatment or were withdrawn. At post-
treatment 65.5% of the CBT-E participants met criteria for remission compared with 33.3% of the IPT
participants (p < 0.001). Over follow-up the proportion of participants meeting criteria for remission
increased, particularly in the IPT condition, but the CBT-E remission rate remained higher (CBT-E 69.4%,
IPT 49.0%; p ¼ 0.028). The response to CBT-E was very similar to that observed in an earlier study. The
ﬁndings indicate that CBT-E is potent treatment for the majority of outpatients with an eating disorder.
IPT remains an alternative to CBT-E, but the response is less pronounced and slower to be expressed.
Current controlled trials: ISRCTN 15562271.
© 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Most studies of mental disorders have focused on speciﬁc dis-
orders in isolation. This strategy has been criticised as it compli-
cates the identiﬁcation of psychopathological processes that
operate across disorders (Insel, 2014; Insel et al., 2010) and it makes
it difﬁcult to identify treatments that are potentially “trans-
diagnostic” in their clinical range.
In 2003 we suggested that there would be value in viewing
eating disorders from a “transdiagnostic” perspective (Fairburn,
Cooper, & Shafran, 2003). We proposed that eating disorder psy-
chopathology is maintained by a largely common set ofent of Psychiatry, Warneford
urn).
r Ltd. This is an open access articlmechanisms, and that treatments capable of addressing these
mechanisms should be effective across the various eating disorder
presentations. Accordingly, we modiﬁed the leading evidence-
based treatment for the eating disorders, a cognitive behavioural
treatment for bulimia nervosa (CBT-BN) (Fairburn, 1981; Fairburn,
Marcus, & Wilson, 1993), to make it suitable for all forms of
eating disorder while at the same time we attempted to make it
more potent (Cooper & Fairburn, 2011; Fairburn et al., 2003). The
resulting treatment, enhanced cognitive behaviour therapy or CBT-
E, has been investigated as a treatment for anorexia nervosa (Dalle
Grave, Calugi, Conti, Doll, & Fairburn, 2013; Dalle Grave, Calugi,
Doll, & Fairburn, 2013; Dalle Grave, Calugi, Ghoch, Conti M, &
Fairburn, 2014; Fairburn et al., 2013; Zipfel et al., 2014) and
bulimia nervosa (Poulsen et al., 2014; Wonderlich et al., 2014), and
in two transdiagnostic samples (Fairburn et al., 2009) that have
included cases of bulimia nervosa, binge eating disorder and the
various unspeciﬁed eating disorder presentations seen in adults
(collectively termed “eating disorder not otherwise speciﬁed” ine under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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indicate that CBT-E is indeed transdiagnostic in its clinical range,
but its relative and absolute effectiveness remain to be established.
Neither are clear because there have been differences across the
studies in the way that CBT-E has been implemented.
The primary aim of the present study was to compare the effects
of CBT-E with those of interpersonal psychotherapy (IPT), the
leading alternative to cognitive behaviour therapy as a treatment
for adult outpatients with an eating disorder. There is evidence
supporting the use of IPT in bulimia nervosa (Agras, Walsh,
Fairburn, Wilson, & Kraemer, 2000; Fairburn, Jones, Peveler,
Hope, & O'Connor, 1993), binge eating disorder (Wilﬂey et al.,
1993, 2002; Wilson, Wilﬂey, Agras, & Bryson, 2010) and, to a
lesser extent, anorexia nervosa (Carter et al., 2011; McIntosh et al.,
2005). IPT has not previously been tested in a broad transdiagnostic
patient sample nor has it been compared with CBT-E. The second
aim was to determine whether the ﬁndings of the original and
largest study of CBT-E (Fairburn et al., 2009) could be replicated
when an equivalent inclusive patient sample was recruited and
CBT-E was implemented in the same way.
2. Method
2.1. Design
A randomized controlled trial was conducted at a catchment
area-based eating disorder clinic in the UK. Eligible patients were
randomized either to CBT-E or IPT delivered over 20 weeks. They
were assessed before and after treatment and then entered a closed
follow-up period during which they were assessed at 20, 40 and 60
weeks post-treatment. During the follow-up period they received
no further treatment unless it was judged necessary on clinical
grounds. The studywas restricted to eating disorder patients whose
bodymass index (BMI) was over 17.5 and under 40.0. The studywas
approved by the local human subjects committee.
2.2. Recruitment
The samplewas recruited from consecutive referrals from family
doctors and other clinicians to a long-established eating disorder
clinic serving central Oxfordshire in the UK. Fig. 1 shows the
CONSORT diagram.
Recruitment was designed to be “inclusive” with few exclusion
criteria. The eligibility criteria were having an eating disorder that
required treatment, as judged both by the referring clinician and,
subsequently, by a senior eating disorder specialist (ZC or CGF);
being aged 18e65 years; having a BMI over 17.5 and under 40.0;
and providing written informed consent after receiving a detailed
description of the study. The exclusion criteria were prior receipt of
a treatment closely resembling CBT-E or IPT (N ¼ 13); a co-existing
general psychiatric disorder that precluded eating disorder-focused
treatment (N ¼ 16); medical instability or pregnancy (N ¼ 13); and
not being available for treatment (N ¼ 13). Examples of co-existing
general psychiatric disorders that precluded immediate entry into
the trial were severe clinical depression, bipolar disorder and
marked agoraphobia. Participants who were receiving ongoing
psychiatric treatment were weaned off this prior to entering the
study, the exception being clinically warranted antidepressant
medication (N ¼ 57) which was kept stable during treatment.
2.3. Treatment
Both treatments were delivered in 20 50-min sessions, preceded
by one 90-min preparatory session, and followed by a review ses-
sion 20 weeks after the completion of treatment.Enhanced cognitive behaviour therapy e CBT-E is a psychological
treatment designed to address eating disorder psychopathology
whatever the eating disorder diagnosis. It is personalised to match
the eating disorder psychopathology of the individual patient
(Fairburn, 2008). The default (“focused”) form of the treatment was
used. It concentrates exclusively on the modiﬁcation of eating
habits, weight-control behaviour, and concerns about eating, shape
and weight.
Interpersonal psychotherapy e IPT is a short-term psychological
treatment designed to identify and address current interpersonal
problems (Klerman, Weissman, Rounsaville, & Chevron, 1984). It
was originally developed as a treatment for depression but in the
1980s it was adapted by the ﬁrst author to make it suitable for the
treatment of bulimia nervosa (Fairburn, 1993). This form of IPT has
been shown to be as effective as CBT-BN but it is substantially
slower to achieve its results (Agras et al., 2000; Fairburn, Marcus,
et al., 1993; Fairburn, Jones, et al., 1993). IPT has also been suc-
cessfully used in the treatment of binge eating disorder (Wilﬂey
et al., 2002; Wilson et al., 2010).
The form of IPT used in the present study has been described in
detail elsewhere (Fairburn, 1993; Murphy, Straebler, Basden,
Cooper, & Fairburn, 2012). It closely resembled IPT for depression
but with minor adjustments so that it could be applied to people
with any eating disorder (Murphy et al., 2012). It included all IPT's
key strategies and procedures including role play.
Therapists e Three therapists took part, two were clinical psy-
chologists and one was a psychiatric nurse practitioner. All had
generic clinical experience and experience treating patients with
eating disorders. One had prior experience implementing CBT-E
and another had experience using IPT. Each therapist received six
months' training from CGF and ZC in both CBT-E and IPT prior to the
formal start of the study. During the study weekly supervision
meetings were led by ZC and CGF with close and equal attention
being paid to the quality of implementation of the two treatments.
All the treatment sessions were recorded and each week selected
sessions were audited by the supervisors.
Treatment ﬁdelitye The quality of delivery of the two treatments
was assessed by independent raters using an adaptation of an in-
strument developed for a prior comparison of CBT-BN and IPT (Loeb
et al., 2005). There were 20 CBT-E items and these addressed
general features of CBT-E, stage-speciﬁc features and the use of
non-cognitive behavioural techniques. The 20 IPT items were
equivalent in their focus but IPT-relevant. All the items were rated
using the same seven-point rating scheme. Following completion
of the treatment phase of the study 120 treatment sessions were
selected at random from the early, middle, and late stages of both
treatments and rated blind by four postgraduate research assistants
who had received training in the use of the rating scale.
2.4. Assessment
Eating disorder features e These were assessed using the 16th
edition of the Eating Disorder Examination interview (EDE)
(Fairburn, Cooper, & O'Connor, 2008) and its self-report version
(EDE-Q6.0) (Fairburn& Beglin, 2008). The EDEwas administered by
assessors who were trained and supervised by MO'C, an expert on
the instrument. The assessors were kept blind to the participants'
treatment condition and had no involvement with treatment.
Operational DSM-IV diagnoses of bulimia nervosa and binge eating
disorder (American Psychiatric Association, 1994) were generated
from the EDE ratings (see Supplementary Table 1), the remaining
participants being given the diagnosis “other eating disorder”
(OED). Two outcome variables were created from the EDE ratings;
the severity of eating disorder features as measured by the global
EDE score (continuous), and the primary outcome variable of being
Fig. 1. The CONSORT diagram.
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deviation (SD) above the community mean (categorical); i.e., below
1.74 (Beglin, 1990). Normative comparisons of this type are widely
used to identify clinically signiﬁcant change (Kazdin, 2003; Kendall,
Marrs-Garcia, Nath, & Sheldrick, 1999).
Psychosocial impairment secondary to eating disorder features e
This was measured using the Clinical Impairment Assessment
questionnaire (CIA) (Bohn & Fairburn, 2008; Bohn et al., 2008).
General psychiatric features e The Structured Clinical Interview
for DSM-IV (First, Gibbon,&Williams,1997) was used at baseline to
identify the presence of co-existing general psychiatric disorders,
and the level of depressive features was measured using the Beck
Depression Inventory (BDI) (Beck, Ward, Mendelson, Mock, &
Erbaugh, 1961).
Treatment suitability and expectancy e These were assessed after
two treatment sessions and suitability was assessed again at the
end of treatment. Both were measured using widely employed
patient-rated visual analogue scales (Agras et al., 2000).2.5. Power and sample size
Sample size calculations were performed a priori with respect to
the comparison of CBT-E and IPT, and they were on an intent-to-
treat (ITT) basis. It was calculated that a sample size of 65 partici-
pants per treatment condition was required to provide 80% power
at two-sided p < 0.05 to detect a difference at the end of treatmentin global EDE change of 0.45 points, assuming a SD of global EDE
change scores of 1.0 (Agras et al., 2000) (i.e., a moderate effect size
of 0.5) and also to detect a difference between the two conditions of
at least 25% in the categorical outcome measure.2.6. Randomization
Participants were allocated to the two treatment conditions by
HAD (who had no involvement in recruitment) using a computer-
based minimization algorithm to balance on gender, eating disor-
der diagnosis, BMI, and the need for participants to remain on
psychotropic medication. When groups were evenly balanced, pre-
prepared blocked randomization lists of varying size were used to
allocate participants to the two conditions.2.7. Statistical methods
The primary analysis was an ITT analysis which included all
randomised participants. Each continuous measure was analysed
using a separate linear mixedmodel with the scores from each time
point treated as a repeated measures outcome. Fixed effects of
treatment (IPT vs CBT-E), time (baseline, end of treatment, and 20,
40 and 60 weeks post-treatment), and the interaction between
treatment and time were speciﬁed, and the estimated baseline
score was constrained to be identical in the two treatment condi-
tions. This is equivalent to adjusting for baseline and permitting the
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time point, but offers the additional advantage that the data from
all participants contribute to the analysis, even if there are missing
data at follow up. An unstructured residual covariance matrix was
used to allow for correlations within participants between the
repeatedmeasures over time. Each binary outcomewas analysed in
a similar fashion using a mixed effects logistic regression model
with the binary indicator from each time point as the repeated
measures outcome. Fixed effects were as for the continuous out-
comes. A random effect of patient was speciﬁed to allow for cor-
relations between repeated measures within participants.
Statistical signiﬁcance was taken at the 5% level (p < 0.05).
A per protocol analysis was also conducted using the same data
analytic strategy as the ITT analysis. It was restricted to those par-
ticipants who were considered by their therapist to have fully
completed treatment.
All the analyses were undertaken by RJ using Stata v13 (Stata-
Corp, College Station, Texas).3. Results
3.1. Sample
One hundred and thirty eligible participants were recruited and
randomized between 2006 and 2011. Their diagnoses were as fol-
lows: bulimia nervosa e 53 participants (40.8%); binge eating dis-
order e 8 participants (6.2%); and “other eating disorder” e 69Table 1
Characteristics of the sample at baseline.
IPT (N ¼ 65)
Mean (SD)
Age (years) 26.8 (8.8)
N (%)
Female 63 (96.9)
Ethnicity:
White 60 (92.3)
Black British 1 (1.5)
Asian Chinese 0 (0.0)
Asian British 1 (1.5)
Mixed 3 (4.6)
Marital Status:
Single, never married 52 (80.0)
Married or living as such 12 (18.5)
Separated or divorced 1 (1.5)
Occupational Social Class:
Higher 18 (27.7)
Intermediate 5 (7.7)
Lower 10 (15.4)
Unclassiﬁable 2 (3.1)
Student 30 (46.2)
DSM-IV Eating Disorder Status:
Bulimia nervosa 28 (43.1)
Binge eating disorder 4 (6.2)
Other eating disorder 33 (50.8)
History of anorexia nervosa 15 (23.8)
Mean (SD)
Duration of eating disorder (years) 11.4 (9.6)
Lowest adult BMI (kg/m2) 19.3 (2.9)
Highest adult BMI (kg/m2) 26.6 (5.6)
N (%)
Current Comorbid Diagnoses (SCID):
Major depressive episode 6 (9.2)
Any anxiety disorder 15 (23.1)
Substance abuse 7 (10.8)
Any Axis 1 disorder 25 (38.5)
Need for psychotropic medication 27 (41.5)
BMI e Body mass index; SCID e Structured Clinical Interview for DSM-IV Axis I Disorde
Missing values e There were 2 missing values for history of anorexia nervosa (IPT: 1 missi
missing). The denominator for percentages is the number of non-missing values.participants (53.1%). Sixty-ﬁve were randomized to CBT-E and 65 to
IPT. The characteristics of the sample are shown in Table 1.
3.2. Suitability, expectancy, therapy quality and attrition
The ratings of treatment expectancy were high and did not
differ between the two treatments (expectancy, mean and SD e IPT
66.1, 18.6; CBT-E 68.1, 20.5). The same was true of treatment suit-
ability (beginning, mean and SD e IPT 69.2, 18.7; CBT-E 76.6, 19.7;
end, mean and SD e IPT 75.5, 21.3; CBT-E 78.2, 24.4). The ratings of
treatment ﬁdelity were also high with over two-thirds of the ses-
sions in both treatments being rated as “excellent” (i.e., ratings of 6
or 7 on the 1 to 7 point rating scale).
Twenty-nine participants (22.3%) did not complete all 20 ses-
sions of treatment or were withdrawn because of lack of response.
The non-completion ﬁgures by diagnosis were as follows: bulimia
nervosa e 32.1% (17/53); binge eating disorder e 0% (0/8); other
eating disorder e 17.4% (12/69).
3.3. Relative effects of CBT-E and IPT
3.3.1. At post-treatment
At post-treatment the levels of eating disorder and general
psychopathology had decreased in both treatment conditions but
the changes were signiﬁcantly greater among the CBT-E partici-
pants (see Table 2 and Fig. 2). The observed proportion of CBT-E
participants in remission (i.e., a global EDE score below 1.74) wasCBT-E (N ¼ 65) All Patients (N ¼ 130)
Mean (SD) Mean (SD)
24.9 (6.4) 25.9 (7.7)
N (%) N (%)
64 (98.5) 127 (97.7)
64 (98.5) 124 (95.4)
0 (0.0) 1 (0.8)
1 (1.5) 1 (0.8)
0 (0.0) 1 (0.8)
0 (0.0) 3 (2.3)
58 (89.2) 110 (84.6)
6 (9.2) 18 (13.9)
1 (1.5) 2 (1.5)
8 (12.3) 26 (20.0)
9 (13.9) 14 (10.8)
11 (16.9) 21 (16.2)
2 (3.1) 4 (3.1)
35 (53.9) 65 (50.0)
25 (38.5) 53 (40.8)
4 (6.2) 8 (6.2)
36 (55.4) 69 (53.1)
21 (32.8) 36 (28.4)
Mean (SD) Mean (SD)
8.4 (7.3) 9.9 (8.6)
18.9 (2.8) 19.1 (2.9)
26.2 (5.4) 26.4 (5.5)
N (%) N (%)
9 (13.9) 15 (11.5)
14 (21.5) 29 (22.3)
2 (3.1) 9 (6.9)
22 (34.4) 47 (36.4)
30 (46.2) 57 (43.9)
rs (First et al., 1997).
ng; CBT: 1 missing) and 1 missing value for any axis I disorder (IPT: 0 missing; CBT: 1
Table 2
Main clinical features at baseline, post-treatment and at 60-week post-treatment follow-up.
Baseline Post-treatment 60-week Follow-up
IPT (N ¼ 65) CBT (N ¼ 65) IPT (N ¼ 60) CBT (N ¼ 58) IPT (N ¼ 49) CBT (N ¼ 49)
Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD) Mean (SD)
Body mass index (kg/m2) 22.8 (4.2) 22.9 (4.4) 23.6 (4.5) 23.5 (4.1) 24.8 (5.1) 24.1 (4.8)
Eating disorder psychopathology (EDE)
Global score 3.52 (1.05) 3.59 (1.01) 2.37 (1.25) 1.57 (1.25) 1.83 (1.28) 1.51 (1.20)
Dietary restraint 3.70 (1.32) 3.71 (1.09) 2.46 (1.61) 1.08 (1.35) 1.71 (1.53) 1.32 (1.53)
Eating concern 2.86 (1.11) 2.81 (1.27) 1.83 (1.40) 1.12 (1.21) 1.24 (1.23) 0.97 (1.09)
Shape concern 4.03 (1.32) 4.08 (1.38) 2.53 (1.34) 1.99 (1.43) 2.30 (1.57) 1.98 (1.48)
Weight concern 3.47 (1.51) 3.77 (1.31) 2.67 (1.65) 2.09 (1.67) 2.08 (1.60) 1.78 (1.41)
Other features
Secondary impairment (CIA) 30.0 (8.3) 30.5 (8.6) 19.6 (12.4) 13.9 (10.4) 12.6 (10.8) 12.4 (12.1)
Depressive features (BDI) 22.8 (10.9) 21.2 (10.8) 14.0 (12.3) 11.8 (11.0) 11.8 (12.6) 12.7 (11.8)
N (%) N (%) N (%) N (%) N (%) N (%)
EDE global score < 1 SD above the
community mean (<1.74)
4 (6.2) 2 (3.1) 20 (33.3) 38 (65.5) 24 (49.0) 34 (69.4)
Eating disorder behaviour (EDE)
Objective bulimic episodes 1 51 (78.5) 54 (83.1) 38 (63.3) 25 (43.1) 20 (40.8) 19 (38.8)
Self-induced vomiting 1 42 (64.6) 41 (63.1) 31 (51.7) 22 (37.9) 19 (38.8) 19 (38.8)
Laxative-taking 1 17 (26.2) 7 (10.8) 12 (20.0) 1 (1.7) 5 (10.2) 1 (2.0)
Absence of all of the above 8 (12.3) 6 (9.2) 13 (21.7) 26 (44.8) 23 (46.9) 22 (44.9)
Cessation of binge eating and purging
if present at baseline (N, %)
e e e e 7/52 (13.5) 22/53 (41.5) 16/41 (39.0) 18/45 (40.0)
Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR) Median (IQR)
Objective bulimic episodes (N) 14 (3, 28) 11 (4, 28) 7 (0, 18) 0 (0, 5) 0 (0, 4) 0 (0, 2)
Self-induced vomiting (N) 14 (0, 40) 5 (0, 25) 1.5 (0, 19) 0 (0, 5) 0 (0, 7) 0 (0, 3)
Laxative-taking (N) 0 (0, 1) 0 (0, 0) 0 (0, 0) 0 (0, 0) 0 (0, 0) 0 (0, 0)
EDEe Eating Disorder Examination (Fairburn et al., 2008); CIAe Clinical Impairment Assessment (Bohn& Fairburn, 2008; Bohn et al., 2008); BDIe Beck Depression Inventory
(Beck et al., 1961); BMI e Body mass index.
Missing values e Immediately post-treatment there were a further 4 missing values for BMI, CIA and BDI (IPT: 1; CBT: 3). At 60-week post-treatment, there were a further 6
missing values for BMI (IPT: 4; CBT: 2), 14 missing for CIA (IPT: 7; CBT: 7) and 10 missing for BDI (IPT: 4; CBT: 6).
Fig. 2. Intent-to-treat remission rates in the present study and the earlier one (Fairburn et al., 2009).
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IPT e 20/60, 33.3%; adjusted OR 8.8; 95% CI 2.6 to 29.5; p < 0.001;
see Table 3). Almost half of the CBT-E participants (44.8%, 26/58)
reported no binge eating, vomiting or laxative misuse at the end of
treatment compared with 21.7% (13/60) in the IPT condition
(adjusted OR 6.7; 95% CI 1.9 to 23.6; p ¼ 0.003).
The changes observed were greater among the participants
who completed treatment but the relative effects of the two
treatments were similar (see Supplementary Tables 1 and 2).
Three-quarters of those who completed CBT-E were in remission
compared with just over a third of those who completed IPT (CBT-
E  36/48, 75.0%; IPT e 20/53, 37.7%; adjusted OR 13.0; 95% CI 3.4to 49.4; p < 0.001; see Table 3).
3.3.2. Over the 60-week post-treatment follow-up
There was high compliance with the 60-week period of post-
treatment follow-up with 79.2% (309/390) of the assessments be-
ing successfully completed. Few of the participants required addi-
tional treatment. Of the 118 participants who were assessed at the
end of treatment and then entered follow-up, seven had further
treatment at some point in the 60weeks and a further seven had up
to ﬁve brief “booster” sessions.
The changes observed during treatment were well maintained
in the CBT-E condition (see Table 2 and Fig. 2). For example, at the
Table 3
Intention-to-treat analysis at post-treatment and at 60-week post-treatment follow-up.
Effect estimates for CBT-E vs IPT post-treatment Effect estimate for CBT-E vs IPT 60-week follow-up
Difference (95% CI) p value Difference (95% CI) p value
Body mass index (kg/m2) 0.14 (0.42e0.71) 0.621 0.59 (1.50e0.32) 0.204
Eating disorder psychopathology (EDE)
Global score 0.81 (1.23e0.40) <0.001 0.28 (0.74e0.18) 0.230
Dietary restraint 1.39 (1.89e0.89) <0.001 0.42 (0.98e0.14) 0.142
Eating concern 0.69 (1.14e0.23) 0.003 0.23 (0.68e0.21) 0.304
Shape concern 0.54 (0.99e0.08) 0.021 0.29 (0.85e0.26) 0.303
Weight concern 0.66 (1.21e0.11) 0.019 0.28 (0.82e0.26) 0.308
Other features
Secondary Impairment (CIA) 6.22 (10.10e2.33) 0.002 1.33 (5.72e3.05) 0.551
Depressive features (BDI) 1.76 (5.86e2.34) 0.399 1.12 (3.40e5.63) 0.628
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
EDE severity score < 1 SD above the
community mean (<1.74)
8.75 (2.59e29.54) <0.001 4.20 (1.17e15.14) 0.028
Eating disorder behaviour (EDE)
Objective bulimic episodes 1 0.24 (0.08e0.75) 0.014 0.80 (0.24e2.66) 0.714
Self-induced vomiting 1 0.22 (0.04e1.09) 0.064 0.84 (0.15e4.79) 0.843
Laxative-taking 1 0.03 (0.00e0.54) 0.018 0.11 (0.00e2.82) 0.183
Absence of all of the above 6.68 (1.89e23.59) 0.003 1.04 (0.29e3.67) 0.954
EDEe Eating Disorder Examination (Fairburn et al., 2008); CIAe Clinical Impairment Assessment (Bohn& Fairburn, 2008; Bohn et al., 2008); BDIe Beck Depression Inventory
(Beck et al., 1961).
Estimated treatment differences are from longitudinal mixed effects linear or logistic regression models which included data from all participants who were randomised (IPT:
65; CBT: 65), account for missing data and repeated measures on individuals over time and adjust for baseline values of the outcome in question.
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and at 60-week follow-up it was 1.51 (SD ¼ 1.20). Over the same
period the proportion of participants in remission increased
slightly from 65.5% (38/58) at the end of treatment to 69.4% (34/49)
at 60-week follow-up (see Fig. 2).
In the IPT condition the level of psychopathology fell over the
period of follow-upwith the result that many of the post-treatment
differences between CBT-E and IPT were no longer statistically
signiﬁcant at 60-week follow-up (e.g. adjusted mean difference in
global EDE score 0.28, 95% CI -0.74 to 0.18, p ¼ 0.23; see Table 3),
an exception being the primary outcome variable of being in
remission which remained higher among the CBT-E participants
than among those who received IPT (CBT-E  34/49, 69.4%; IPT e
24/49, 49.0%; adjusted OR: 4.2; 95% CI: 1.2 to 15.1; p ¼ 0.028; see
Table 3 and Fig. 2).
The remission rates during the period of follow-up were higher
among those who completed treatment but the relative effects of
the two treatments remained similar (see Supplementary Tables 2
and 3). The proportion of participants in remission at 60-week
follow-up was 70.0% (28/40) in the CBT-E condition and 50.0%
(23/46) among those who received IPT (adjusted OR 3.8; 95% CI 1.0
to 14.6; p ¼ 0.049).
3.4. Absolute effects of CBT-E
Fig. 2 shows the proportion of participants at each assessment
point with a global EDE-Q score below 1.74, together with the
equivalent data for CBT-E (focused version) from the earlier study
(Fairburn et al., 2009) analysed using the statistical approach
described above. It can be seen that in both studies the effects of
CBT-E were substantial and well maintained. Furthermore, the
magnitude of the response to CBT-E was remarkably similar in the
two studies; the remission rates at the end of treatment being 67%
in study 1 and 66% in study 2, and at 60-week post-treatment
follow-up 63% and 69% respectively.
4. Discussion
This is the second randomised controlled trial to focus on the
effects of CBT-E in a broad transdiagnostic sample of adultoutpatients with an eating disorder (BMI >17.5 to <40.0). The ﬁrst
study recruited patients from two well-established eating disorder
clinics in England, one in Leicestershire and the other in Oxford-
shire (Fairburn et al., 2009). Both receive the great majority of re-
ferrals from the surrounding rural and urban areas. The present
study recruited from the Oxfordshire-based clinic alone. In both
studies care was taken to ensure that the great majority of referrals
with a sufﬁciently severe eating disorder were eligible to take part.
The resulting participant groups were very similar to each other.
Both included the majority of those who were suitable and willing
to be treated as outpatients, and they comprised patients with
bulimia nervosa, binge eating disorder, the many and varied un-
speciﬁed eating disorder presentations (Fairburn et al., 2007), and
less underweight cases of anorexia nervosa (BMI > 17.5).
The ﬁrst study compared the focused and broad forms of CBT-E,
and it included a delayed treatment comparison condition
(Fairburn et al., 2009). The present study involved a comparison of
the focused form of CBT-E (the default version) with IPT, the leading
alternative psychological treatment for adults with an eating dis-
order. Great care was taken to avoid any possible allegiance effects
although none was likely as both treatments were devised by our
group and we are known to be advocates of both CBT-E and IPT for
eating disorders, The therapists received equivalent amounts of
training in the two treatments and equivalent emphasis was placed
upon them in the weekly supervision meetings. The independent
ratings of treatment ﬁdelity indicated that both were well imple-
mented and there was no difference between the treatments in the
ratings of suitability and expectancy.
The main aim of the study was to determine the relative effects
of CBT-E and IPT. It was found that two-thirds of thosewho received
CBT-E were in remission at the end of treatment compared with
one-third of those who received IPT (CBT-E 66%; IPT 33%). This
difference between the two treatments remained statistically sig-
niﬁcant 60 weeks later despite signiﬁcant additional improvement
in the IPT condition (CBT-E 69%; IPT 49%). The different temporal
pattern of response to the two treatments (shown in Fig. 2) re-
sembles that seen in the earlier studies of bulimia nervosa (Agras
et al., 2000; Fairburn, Marcus, et al., 1993; Fairburn, Jones, et al.,
1993). It is perhaps not surprising that CBT-E operates more
rapidly than IPT given that it directly addresses the eating disorder
C.G. Fairburn et al. / Behaviour Research and Therapy 70 (2015) 64e7170psychopathology whereas IPT is likely to produce change indirectly
via improvements in interpersonal functioning.
The second aim was to see whether the ﬁndings of the original
and largest study of CBT-E (Fairburn et al., 2009) would be repli-
cated when an equivalent patient sample was recruited and CBT-E
was implemented in a consistent way following the treatment
guide. It emerged that CBT-E had a remarkably similar effect (see
Fig. 2). Using the statistical approach described above, two-thirds of
the participants in both studies were in remission by the end of
treatment, despite an average duration of eating disorder at pre-
sentation of 8.1 years in the original study (Fairburn et al., 2009)
and 8.4 years in the present one. Furthermore in both studies the
changes were well maintained. Sixty-three percent of the partici-
pants in the original study and 69% in the present one were in
remission at the end of the 60-week closed period of follow-up yet
there was minimal exposure to additional treatment.
A question of great importance is whether the effects seen in
these RCTs are mirrored in “real world” clinical settings. In such
settings the patients may be more heterogeneous; there may be a
waiting list for treatment; and the therapists generally receive
limited training and supervision. With regard to patient charac-
teristics, Wales and colleagues showed that the Leicestershire RCT
sample was extremely similar to the patients routinely seen in the
same long-established clinic (Wales, Palmer, & Fairburn, 2009).
Three studies have decribed the response rates obtained in real
world settings. Byrne and colleagues in Australia reported the
outcome of 125 consecutive patients treated with CBT-E (Byrne,
Fursland, Allen, & Watson, 2011) and Knott and colleagues in a
National Health Service (NHS) clinic in Wales described the
response of a further 272 patients (Knott, Woodward, Hoefkens, &
Limbert, 2015). In a third report Turner and colleagues (Turner,
Marshall, Stopa, & Waller, 2015) described the outcome of 203
patients attending an NHS clinic in England, all of whom received
an amalgam of CBT-E and the overlapping approach of Waller and
colleagues (Waller et al., 2007). In all three cohorts (comprising a
total of 600 patients) the outcome of the patients who completed
CBT-E was similar to that reported here and in the original 2009
CBT-E trial. The main difference was that the treatment completion
rates were lower. It therefore seems that CBT-E can be successfully
used in routine clinical settings, the main challenge being to
enhance patient retention. We are not aware of equivalent “real
world” data on the use of IPT to treat eating disorders.
The present study had three signiﬁcant strengths. First, like its
predecessor, a clinically relevant sample was recruited from a long-
established clinic using “inclusive” eligibility criteria. Second, the
sample was transdiagnostic in composition. The great majority of
adult outpatients with an eating disorder were represented. Third,
we took pains to ensure that both treatments were implemented
well and according to their respective protocols.
Five provisos must also be noted. First, this was a study of adult
participants. It cannot be assumed that the same ﬁndings would be
obtained with younger patients. CBT-E has been studied as a
treatment for adolescents with anorexia nervosa (Dalle Grave,
Calugi, Conti, et al., 2013; Dalle Grave, Calugi, Doll, et al., 2013;
Dalle Grave, Calugi, Ghoch, Conti, & Fairburn, 2014) and the re-
sults appear promising but it has not been compared with other
treatments for this age group nor has data been published on its use
with adolescents with other eating disorder diagnoses. Second, as
the study was restricted to participants with a BMI over 17.5 and
under 40.0, it would not be appropriate to generalise the ﬁndings to
patients with a BMI outside this range. This is important to note
while keeping in mind the fact that the majority of adult out-
patients with an eating disorder have a BMI within the range
studied. Third, the duration of post-treatment follow-up was just
60 weeks long.While this covers the time of greatest risk of relapse,a longer period of follow-up would be of interest and is underway.
Fourth, only the focused form of CBT-E was studied: the more
complex “broad” form was not used. This decision was taken as
there is evidence that it is no more effective overall than the
focused form (Fairburn et al., 2009) yet it is more difﬁcult to deliver.
Furthermore, as the “interpersonal module” of broad CBT-E
(Fairburn, 2008) overlaps substantially with IPT in its strategies
and procedures, to have included it in the design would have
confounded the comparison. Lastly, we have not reported on me-
diators or moderators of response to the two treatments. In sepa-
rate publications we will examine whether there are moderators of
response to CBT-E and IPT. We will also test speciﬁc mediational
hypotheses concerning how both CBT-E and IPT operate using
detailed within-treatment data collected for this purpose (Murphy,
Cooper, Hollon, & Fairburn, 2009).
The ﬁndings presented here, taken together with those from the
earlier study (Fairburn et al., 2009), indicate that CBT-E is a potent
treatment that can be used with the majority of adult outpatients
with an eating disorder; namely, those with a BMI over 17.5 and
under 40.0. This broad clinical range makes the treatment of
considerable value to clinicians. The ﬁndings also suggest that IPT
has a broad clinical range although the response is slower to be
expressed and is less pronounced. Lastly, the results underscore the
value of research on transdiagnostic participant samples, as advo-
cated by the RDoC initiative (Insel, 2014; Insel et al., 2010), as
ﬁndings of this nature could not emerge from single-diagnosis
research designs.
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